Anti-body R&D company Escugen closes Pre-A raising tens of millions in RMB
On August 24, Shanghai Shijian Biotechnology Co., Ltd., or Escugen announced the completion of its Pre-A round of financing worth tens of millions of yuan.
JD Xintonglu covers more than 300 cities in China
On August 24, Zheng Hongyan, Vice President of JD.com Group and President of the JD.com’s Xintonglu Department that was in charge of the omni-channel retail business, announced that the JD Xintonglu would upgrade its cooperation with the supermarkets...
Two former executives of Baidu.com join Bytedance
Recently, Wu Haifeng and Sun Wenyu, two of the five executives who had quitted Baidu out of the blue in May last year, have joined Bytedance.
Dongfeng Motor plans to deploy more than 200 Robotaxi in Wuhan
On August 25, Dongfeng Company announced that it will join forces with WeRide.ai, Deeproute.ai, UISEE, AutoX and other autonomous driving companies to establish the country’s largest autonomous driving network in the Wuhan Development Zone.
360 Finance's Q2 revenue increased by 50.3% year-on-year
Data show that 360 Finance's revenue in the second quarter was 3.34 billion yuan, a year-on-year increase of 50.3%.
Guangdong to ban non-degradable plastic tableware by end of 2020
Recently, the official website of the Guangdong Provincial Development and Reform Commission issued the Implementation Opinions on Further Strengthening the Control of Plastic Pollution.
Phase III clinical trial of China's covid-19 inactivated vaccine launched in Argentina
The world’s first inactivated COVID-19 vaccine developed and produced by Sinopharm Group’s China National Biotec Group (CNBG) was approved by the National Food, Drugs and Medical Technology Administration (ANMAT) under the Ministry of Health of...
China's first COVID-19 vaccine produced by insect cells obtained clinical trial approval
The recombinant protein COVID-19 vaccine developed by a key laboratory of biological therapy of West China Hospital of Sichuan University was approved by the State Drug Administration for clinical trials, according to Jiemian.com.
Shanghai will continue to build global asset management center: official
Shanghai will make every effort to create a world-class financial development environment, further strengthen the function of global resource allocation, and further connect the domestic and international double markets in a strategic way, a local...
China started emergency use of Covid-19 vaccine on July 22
China has officially launched the emergency use of the Covid-19 vaccine on July 22, Zheng Zhongwei, an official of the National Health Commission, said on CCTV's Dialogue program.
Jack Ma decreases shareholding in Ant Group's employee shareholding entity
On August 21, Hangzhou Yunbo Investment Consulting Co., Ltd., as Ant Group's employee shareholding entity, had an industrial and commercial change, with Jack Ma's shareholding in the company dropping from 100% to 34%, Tianyancha App showed.
D2M Biotherapeutics completes $10 million Pre-A round of financing
D2M Biotherapeutics, a tumor immunological drug developer, recently completed a Pre-A round of US$10 million in financing led by Apricot Capital (Shanghai).
World's first new energy UHV transmission channel starts operation
As of the 21st, the world's first large UHV power transmission channel mainly for the transmission of new energy, which is called Qinghai-Henan ±800 kV UHV DC Project, has delivered 1 billion kwh of green power to Henan, with an average daily power...
China Securities ranks first in underwriting sponsorship revenue this year
As of August 23, 244 companies have completed IPOs and listed publicly this year, with a total initial fundraising total of 289.748 billion yuan. Both the number of IPOs and the actual fundraising scale have exceeded that of last year.
Yitu Tech business scope adds medical equipment sales and value-added telecommunications services
Shanghai Yitu Network Technology (Yitu Tech) has undergone many industrial and commercial changes recently, according to Tianyancha APP.